| December 21, 1999 |
December 21, 1999
Cerus Corporation Announces $25 Million Private Placement of Common Stock
|
| December 9, 1999 |
December 9, 1999
Cerus Corporation Appoints C. Raymond Larkin, Jr. to Board of Directors
|
| December 6, 1999 |
December 6, 1999
Cerus Reports Preclinical Study Results on Its Program In Allogeneic Bone Marrow Transplant
|
| December 6, 1999 |
December 6, 1999
Cerus Presents Data On Pathogen Inactivation Systems For Blood Transfusion Products
|
| November 4, 1999 |
November 4, 1999
Cerus Corporation Adopts Stockholder Rights Plan
|
| October 26, 1999 |
October 26, 1999
Cerus Corporation Announces Third Quarter Results
|
| October 26, 1999 |
October 26, 1999
Cerus Completes Successful Phase 1B Clinical Trial of its Red Blood Cell Pathogen Inactivation System Study Demonstrates Viability of Treated Red Blood Cells; No Immune Response Detected
|
| October 5, 1999 |
October 5, 1999
Cerus Receives $800,000 NIH Grant for Allogeneic Bone Marrow Transplant Research
|
| July 27, 1999 |
July 27, 1999
Cerus Corporation Announces Second Quarter Results
|
| July 22, 1999 |
July 22, 1999
Cerus and Baxter Begin Enrollment in U.S. Phase 3 Trial of System to Improve the Safety of Platelet Transfusions
|
| July 7, 1999 |
July 7, 1999
Cerus Corporation Appoints Vice President of Legal Affairs
|
| June 30, 1999 |
June 30, 1999
Cerus Initiates Phase 1 Allogeneic Bone Marrow Transplant Study
|
| May 12, 1999 |
May 12, 1999
Cerus Receives FDA Clearance to Proceed with Phase 3 Study of Its Fresh Frozen Plasma Pathogen Inactivation System
|
| May 11, 1999 |
May 11, 1999
Cerus Initiates Transfusion In Phase 1b Clinical Trial Of Its Pathogen Inactivation System For Red Blood Cells
|
| May 11, 1999 |
May 11, 1999
Cerus Initiates Transfusion in Phase 1B Clinical Trial Of Its Pathogen Inactivation System for Red Blood Cells
|
| May 7, 1999 |
May 7, 1999
Cerus Corporation Appoints Chief Financial Officer
|
| April 21, 1999 |
April 21, 1999
Cerus Corporation Announces First Quarter Results
|
| March 31, 1999 |
March 31, 1999
Cerus Corporation Completes Stock Offering
|
| March 4, 1999 |
March 4, 1999
Baxter Healthcare Purchase $9.5 Million of Cerus Corporation Convertible Preferred Stock
|
| February 23, 1999 |
February 23, 1999
Cerus Receives FDA Clearance to Proceed With Clinical Trials Of Its System For Allogeneic Bone Marrow Transplantation
|
| February 11, 1999 |
February 11, 1999
Cerus Corporation Announces Proposed Stock Offering
|
| January 26, 1999 |
January 26, 1999
Cerus Corporation Announces Fourth Quarter and 1998 Results
|
| January 26, 1999 |
January 26, 1999
Cerus Sets Preliminary Parameters For U.S. Phase 3 Platelet Trial
|
| January 20, 1999 |
January 20, 1999
Cerus Corporation Announces New CFO and Promotions to Vice President for Commercialization
|